The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 15 results:
Author Title Type [ Year(Asc)]
Filters: Author is Patoulias, D  [Clear All Filters]
2020
Patoulias, D., & Papadopoulos C. (2020).  Acute heart failure, type 2 diabetes and loop diuretic use: any adjunct role for sodium-glucose cotransporter-2 inhibitors?.
Patoulias, D., & Papadopoulos C. (2020).  Glucagon-like peptide-1 receptor agonists or sodium–glucose cotransporter-2 inhibitors as add-on therapy for patients with type 2 diabetes? A systematic review and meta-analysis of surrogate metabolic endpoints.
Patoulias, D., & Papadopoulos C. (2020).  Meta-Analysis Assessing the Cardiovascular Efficacy of Sodium-Glucose Co-Transporter-2 Inhibitors According to Baseline Treatment of Interest.
Patoulias, D., & Papadopoulos C. (2020).  Meta-Analysis Assessing the Effects of Allopurinol on Left Ventricular Mass and Other Indices of Left Ventricular Remodeling as Evaluated by Cardiac Magnetic Resonance Imaging..
Patoulias, D., & Papadopoulos C. (2020).  Meta-analysis Evaluating the Risk of Atrial Fibrillation With Newer Antidiabetics Across the Cardiovascular and Renal Outcome Trials.
Patoulias, D., & Papadopoulos C. (2020).  Meta-analysis of Dedicated Renal Outcome Trials Assessing the Cardio-renal Efficacy of Sodium-Glucose Co-transporter-2 Inhibitors in Patients With Chronic Kidney Disease and Albuminuria.
Patoulias, D., & Papadopoulos C. (2020).  Pericardial fat in type 2 diabetes: not just a biomarker, but a promising treatment target?.
Patoulias, D., & Papadopoulos C. (2020).  Postdischarge antidiabetic treatment in patients with type 2 diabetes and acute coronary syndrome: Time for a change?.
Patoulias, D., & Papadopoulos C. (2020).  Postdischarge antidiabetic treatment in patients with type 2 diabetes and acute coronary syndrome: Time for a change?.
Patoulias, D., & Papadopoulos C. (2020).  Prognostic value of arterial stiffness measurements in cardiovascular disease, diabetes, and its complications: The potential role of sodium-glucose co-transporter-2 inhibitors.
Patoulias, D., & Papadopoulos C. (2020).  Sodium-glucose co-transporter-2 inhibitors, cardiovascular outcomes and the impact of gender: Class effect or statistical play of chance?.
Patoulias, D., & Papadopoulos C. (2020).  Sodium–Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions.
Patoulias, D., & Papadopoulos C. (2020).  Time to assess the effects of sodium–glucose co-transporter-2 inhibitors on the ‘forgotten' right ventricle?.
Patoulias, D., & Papadopoulos C. (2020).  Updated Meta-analysis Assessing the Effect of Sodium-Glucose Co-transporter-2 Inhibitors on Surrogate End points in Patients With Heart Failure With Reduced Ejection Fraction.
Patoulias, D., & Papadopoulos C. (2020).  Updated Meta-Analysis of Trials Assessing the Cardiovascular Efficacy of Sodium-Glucose Co-Transporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Black Patients.

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.